Universe Pharmaceuticals

UPC · NASDAQ

$3.93+$0.38 (+10.70%)TodayMarket open · Oct 21, 11:15 AM ET · Delayed 15 min

Prev close $3.55

About UPC

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The firm is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.

Employees: 225
Headquarters: Ji'an, Jiangxi
Listed: Mar 23, 2021
Sector: Health Care
Industry: Pharmaceuticals
Website: universe-pharmacy.com

Leadership

Universe Pharmaceuticals executives
Name	Title	Since	Age
Gang Lai	—	—	54
Lin Yang	—	—	46
Baochang Liu	—	—	42
Jiawen Pang	—	—	54
H. David Sherman	—	—	73
Ding Zheng	—	—	44
Tina Xiao	—	2022	—

Similar companies

Companies in the same industry as Universe Pharmaceuticals

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.